The sympathetic nervous system plays an essential role in the control of total peripheral vascular resistance and blood flow, by controlling the contraction of small arteries. Perivascular sympathetic nerves release ATP, norepinephrine (NE) and neuropeptide Y. This review summarizes our knowledge of the intracellular Ca 2+ signals that are activated by ATP and NE, acting respectively on P2X 1 and α 1 -adrenoceptors in arterial smooth muscle. Each neurotransmitter produces a unique type of post-synaptic Ca 2+ signal and associated contraction. The neural release of ATP and NE is thought to vary markedly with the pattern of nerve activity, probably reflecting both pre-and post-synaptic mechanisms. Finally, we show that Ca 2+ signaling during neurogenic contractions activated by trains of sympathetic nerve fiber action potentials are in fact significantly different from that elicited by simple bath application of exogenous neurotransmitters to isolated arteries (a common experimental technique), and end by identifying important questions remaining in our understanding of sympathetic neurotransmission and the physiological regulation of contraction of small arteries.
Introduction
The autonomic nervous system controls the activity of smooth muscles in the cardiovascular-renal system, gastrointestinal system, and urogenital system. Afferent and efferent (sensory) nerves release a 'cocktail' of neurotransmitters that control the contractile and trophic state of the smooth muscle cells [1] . These neurotransmitters activate several cell signaling systems, including the ubiquitous intracellular Ca 2+ signaling systems [2] . Yet, neurogenic Ca 2+ signaling in smooth muscle (that elicited by neurally released transmitters, as opposed to exogenously applied receptor agonists) has been investigated so far only in a few types of arteries, the vas deferens, the bladder and the uterus. Until now, this remarkable state of affairs reflected the difficulty of observing intracellular (Ca 2+ ) in the muscle cells of intact organs in which nerves can be stimulated. Our intent in this article is to review what is known about the changes in intracellular (Ca 2+ ) that are elicited by sympathetic nerves, and to identify the important remaining questions.
Many factors are involved in regulating arterial diameter including the central and peripheral nervous systems, endothelial cells, circulating hormones, locally released substances, blood pressure, blood flow, and intrinsic mechanisms of smooth muscle. In arteries that contribute significantly to total peripheral resistance, such as mesenteric small arteries [3, 4] (which control blood flow to the intestine), control of smooth muscle contraction by the sympathetic nervous system is of major importance. This control is complex, involving multiple neurotransmitters and receptors, as well as complex patterns of nerve fiber activity. It is known that at least 3 different sympathetic neurotransmitters [ATP, norepinephrine (NE), and neuropeptide Y (NPY)] are released from sympathetic varicosities, and that their effects vary with the pattern of nerve fiber activity. Actions of the transmitters to elicit Ca 2+ signaling in smooth muscle are believed to be synergistic, although detailed information is lacking. Finally, the probability of transmitter release at a single sympathetic nerve terminal is low (~0.05) and the pattern of sympathetic nerve activity in vivo is complex, consisting of single action potentials (AP) or bursts of AP superimposed on a background of tonic activity [5, 6] . All 3 sympathetic cotransmitters, NE, ATP, and NPY contribute to sympathetically mediated vasoconstriction. Stimulation of the nerves supplying the rat mesenteric arterial bed (the tissue with which we are mainly concerned in this review) elicits an increase in perfusion pressure that can be blocked completely only by the combined administration of prazosin, suramin and BIBP 3226 ((R)-N2-(diphenacetyl)-N-(4-hydroxyphenyl) methyl)-D-arginineamide) (a selective α 1 -adrenoceptor antagonist, a non-selective antagonist of all P2X receptor subtypes, and a selective antagonist of the NPY receptor subtype, Y 1 ), respectively [7] . Neurogenic contractions of isolated mesenteric small arteries are typically bi-phasic ( Figure 1) , with the small, initial transient component being attributed to purinergic (P2X) receptors, and the later, slow, large component being attributed to neurally released NE. However, the relative importance of each type of receptor depends on the size and type of the artery, as well as on the pattern of sympathetic nerve activity. In mesenteric arteries, the purinergic component of the contraction is relatively large in very small arteries (compared to the α 1 -receptor-mediated component), and the purinergic component predominates during brief bursts of sympathetic nerve fiber activity [8] . Indeed, it has recently been concluded that, "all three cotransmitters contribute significantly to vascular responses and their contribution varies markedly with impulse numbers" [9] . The varying contribution of the transmitters under different conditions is the result of both pre-and post-synaptic factors.
Our goal in this review is to summarize recent new information on sympathetic neuromuscular transmission and the resultant Ca 2+ signaling in the smooth muscle cells of small arteries during neurogenic contractions. Ca 2+ signaling during neurogenic contractions activated by trains of sympathetic nerve fiber action potentials is in fact significantly different from that elicited by the simple application of exogenous neurotransmitters (both ATP and NE) to isolated arteries (or single isolated smooth muscle cells). We end by identifying important questions remaining in our understanding of sympathetic neuromuscular transmission and the physiological regulation of arterial smooth muscle contraction by the sympathetic nervous system.
Sympathetic nerves in isolated small arteries
The perivascular nerve fibers present in rat mesenteric small arteries are of 2 major types: sympathetic and 'sensory'. The latter, which will not be discussed further here, are the so-called non-adrenergic, non-cholinergic (NANC) or 'sensory' nerves, whose cell bodies are located in the dorsal root ganglia. The perivascular sympathetic nerves that remain with isolated arteries consist of the neuroeffector system, that is, the post-ganglionic fibers (cell bodies located in paravertebral ganglia) and their nodal areas of axoplasmic specialization, that is, varicosities and synaptic junctions with the smooth muscle. Experimentally, the perivascular nerves of an isolated artery can easily be electrically stimulated to release transmitters. The function of NANC nerves may be blocked through the use of capsaicin [10] , thus permitting selective activation of the sympathetic nerves.
We next review very briefly the salient features of current concepts on the pre-synaptic and post-synaptic mechanisms that are involved in sympathetic neuromuscular transmission at such junctions, particularly those involved in the differential release of sympathetic cotransmitters. A major physiological phenomenon to be explained is that the effects of ATP are predominant at low frequencies of sympathetic nerve fiber activity, while those of NE are predominant at high frequencies. A neurogenic contraction from a rat small mesenteric artery. The artery was mounted between two glass pipettes. One pipette was attached to a servo-controlled pressure-regulating device (Living Systems), while the other was attached to a closed stopcock. The inter-luminal pressure was set to 70 mmHg. Electrical field stimulation (EFS) (via two platinum electrodes placed parallel to the long axis of the artery) was applied for the period indicated by the bar. EFS characteristics where 0.2 ms and 40V. The small initial component is attributed predominantly to purinergic receptors (P2X 1 ), the later slower, larger component being attributed to neurally released nor-epinephrine (previously unpublished data of the authors).
Synaptic vesicles in sympathetic varicosities
Varicosities on the sympathetic perivascular nerves in rat mesenteric small arteries contain several different types of synaptic vesicles, probably containing different proportions of NE, ATP and NPY. These vesicles may have different origins (cell body vs formation at synapse) and mechanisms of exocytosis (including regulation by varicosity Ca 2+ ). Rat mesenteric arteries adrenergic nerve terminals contain 3 types of vesicles: large dense-cored vesicles (LDCV; ~100 nm diameter), small dense core vesicles (SDCV; ~50 nm diameter) and small clear vesicles (SCV; ~50 nm diameter) [11] [12] [13] . LDCV comprises 5% of the total vesicles in a varicosity, with the remainder being small vesicles (SV) [10] . The majority of the SV have (88%) dense cores (SDCV); the remainder without, SCV [10] . NE and ATP are thought to be stored in all vesicle types, but in different proportions. It is generally agreed that the ATP and NE are released from different nerve terminal stores [12, 14] although the type of vesicles involved is not generally agreed upon. The exact vesicular origin of the released transmitters remains to be elucidated and may be species and tissue specific.
Post junctional receptors
Post-synaptic receptors for ATP Receptors for purine (ATP, ADP) and pyrimidine (UTP, UDP) nucleotides are presently divided into 2 families: ionotropic P2X receptors (7 cloned subtypes) and metabotropic P2Y receptors (6 cloned subtypes) [15] . In the cardiovascular system, P2X receptors are expressed predominantly on smooth muscle (but are present on endothelial cells), and P2Y receptors are predominantly expressed on endothelial cells (also present on smooth muscle cells). P1 receptors will not be considered here except as they may be activated by adenosine produced by endothelial nucleotidase activity [16, 17] . Neurally-released ATP activated P2X receptors (ligand-gated ion channels) on smooth muscle to produce the excitatory junction potentials, and activated P2Y receptors on endothelium (G proteincoupled receptors) to produce endothelium dependent hyperpolarizing factor. In rat mesenteric arteries, the predominant P2X receptor is P2X 1 [18] . Neurally-released ATP binds to both P2X and P2Y receptors. While 'overflow' of ATP may be quantified chemically, only the effect of ATP on P2X receptors is detectable with electrical and optical methods. There is no doubt that neurally-released ATP produces the excitatory junction currents (EJCs), junctional Ca 2+ transients (jCaT) and in vas deferens, the neuroeffector Ca 2+ transients (NCT ) and osmotic pressure [12] and sensitivity to heptanol [19] . Considering the work of these authors and the 'dual vesicle' hypothesis of Stjarne [12] , it may be speculated that the 'large and fast' EJC arise from the release of the 'big quanta' type of SV, and that the 'small and slow' EJC arise from the 'small quanta' type of SV. jCaT and NCT would arise from the 'big quanta' SV; the extent to which work in the smooth muscle of vas deferens may apply to that of arteries is not known.
Post-synaptic receptors for NE The second sympathetic cotransmitter, NE, binds to adrenoceptors, the classification and function of which have been reviewed recently [20] . At least 9 subtypes of vascular adrenoceptors have been identified [21] : α 1A , α 1B, α 1D , α 2A/D , α 2B , α 2C , β 1 , β 2 , and β 3 . There is also believed to be a low affinity (to prazosin) state of α 1A -adrenoceptors, known as the α 1L -adrenoceptors, and they are found in various vascular beds [22] . A useful heuristic generalization is that α 1 -adrenoceptors are located postjunctionally on vascular smooth muscle and have a primary role in controlling arterial tone, particularly in small resistance arteries. This accounts for the predominant use of the synthetic α 1 -adrenoceptor agonist, phenylephrine (PE), in the majority of experimental studies. Exogenous activation of adrenoceptors using PE and the use of an α 1B -knockout mouse has permitted the conclusion that α 1D is most important in conduit arteries, while α 1A is most important in small arteries and α 1B was reported to have a minor contribution [23] . Recent studies using nerve-evoked contraction, also in small arteries isolated from α 1D -knockout mouse, have shown the importance of α 1A -adrenoceptors as the predominant subtype and α 1D having a small, but significant role [24] . Prejunctionally, transmitter release at sympathetic varicosities (neuromuscular junctions) is importantly regulated by α 2A/D and α 2C . Endothelial cells have at least 5 subtypes of adrenoceptors: α 2A/D , α 2C , β 1 , β 2 , and β 3 . Adrenergic signaling mechanisms in arterial smooth muscle have been reviewed recently [25] , with the emphasis on Ca 2+ activation of contraction and Ca 2+ -sensitizing mechanisms activated by bath-applied phenylephrine.
Neurally-released NE has been detected classically by chemical methods in the effluent of neurally stimulated arteries ('overflow experiments') or by amperometric methods, in which the oxidation of NE on the surface of a carbon fiber electrode is detected as an electrical current. Most significantly, the release of single quanta of NE has been detected from the surface of rat mesenteric small arteries through the use of carbon fiber microelectrodes (CFmE). These microelectrodes are 7 µm in diameter and are believed to detect the release of NE quanta from a distance of 8 µm [14] . Furthermore, spontaneous oxidation currents (SOC) were also recorded. These authors speculated that the SOC arose from NE released from large dense-cored vesicles (LDV). An important observation was that α-latrotoxin increased the frequency of SOC about 4-fold, but increased the frequency of spontaneous excitatory junction potentials (which monitor packeted or quantal ATP release) by 30-fold. This observation supports the suggestion that SEJP (spontaneous excitatory junction potentials activated by released ATP ) and SOC (NE release) occur through different synaptic vesicles, under these conditions.
In most vascular beds, α 1 -adrenoceptors play an important role in vasoconstriction. The relative importance of the different α 1 -adrenoceptor subtypes in regulation of peripheral resistance and systemic arterial blood pressure is not clear, as the contribution of different subtypes to vasoconstriction differs with the mode of activation and species [26] . For example, studies in rat mesenteric small arteries using exogenous agonists have revealed the role of α 1A - [27, 28] or α 1B - [29] or α 1L -adrenoceptors [30] . In contrast, nerve-evoked contractions in rat mesenteric arteries were predominantly mediated by α 1A -adrenoceptors [27, 28] . Further, studies in mesenteric small arteries using α 1B -adrenoceptor knockout mouse have revealed the predominance of α 1A -adrenoceptors in vasoconstriction to phenylephrine [23] and nerve-evoked contractions showed the predominance of α 1B -adrenoceptors [31] . Therefore, it is important to study in vivo preparations to understand the clinical relevance of the α 1 -adrenoceptor subtypes involved in vasoconstriction.
Post-synaptic receptors for NPY The third sympathetic cotransmitter, NPY, is believed to enhance the effects of both ATP and NE, by acting on post-junctional NPY-Y 1 receptors [32] . Five distinct NPY receptors (Y 1 , Y 2 , Y 4 , Y 5 , and Y 6 ) have been cloned [33] . Y 1 receptors are believed to be the major type present post-junctionally in the cardiovascular system and to mediate the response to NPY, although the possible involvement of pre-and post-junctional Y 2 receptors has been suggested. NPY receptors act via pertussis toxin-sensitive G proteins. A major effect of their activation is the inhibition of adenylyl cyclase. NPY shifts agonist dose-response curves to the right [34] . It has been suggested that NPY activates mesenteric small arteries through 2 different mechanisms: activation of non-selective cation channels and consequent Ca 2+ entry, and the inhibition of the hyperpolarization produced by cAMP [35] (cyclic adenosine monophosphate).
Differential release of ATP and NE
There is good evidence that ATP is the predominant sympathetic effector in response to 'single' action potentials, while at high frequencies of activation, NE is the predominant sympathetic effector. This may result from the pre-and post-synaptic mechanisms discussed earlier. Low frequency electrical field stimulation (EFS; eg 1 Hz) elicits relatively small, brief, phasic contraction of rat mesenteric arteries, whereas higher frequency EFS (eg 16 Hz) elicits larger, sustained contractions. The irreversible adrenergic antagonist, phenoxy-benzamine, abolished the response to bath-applied norepinephrine, but reduced the response to a single nerve stimulus by only 20% [36] . Conversely, the stable ATP analogue, α,β-methylene ATP (which desensitizes P2X receptors), reduced the response to a single pulse by 70%, while reducing the contraction to high frequency stimulation only 10%. Similarly, in the rabbit ear artery, it has been concluded that 'short pulse bursts at low frequency favor the prazosin-resistant (purinergic) component of the response' [37] .
Post-synaptic Ca 2+ signaling
Recent work has revealed in detail the Ca 2+ signals in smooth muscle cells during sympathetically-mediated neurogenic contractions of small arteries [38] and vas deferens [39] . There are differences between these 2 tissues (which have very different functions), and we will focus here on what is known about sympathetic neuromuscular transmission and neurogenic contractions of vascular smooth muscle. [40] that has been termed a 'jCaT', for junctional Ca 2+ transient. It was shown that these Ca transients arise in the vicinity of perivascular nerves [38] or even directly beneath single visualized nerve fibers [40] . The confocal images of jCaT in Figure  2 were obtained in pressurized (70 mmHg) rat mesenteric small arteries subjected to EFS. Low frequency, low voltage stimulation (0.67 Hz, 0.2 ms) excited nerve fibers without causing an appreciable contraction. This was referred to this as 'sub-threshold' EFS, as it is sub-threshold for muscle contraction. Thus, in these experiments, motion did not occur and the characteristics of the jCaT could be studied in detail. Figure 2 illustrates the basic appearance of jCaT in line-scan images and demonstrates that: (1) nerve fibers are being excited by each EFS pulse; (2) a jCaT occurs nearly simultaneously with an EFS pulse; (3) jCaT occur near nerve fibers; and (4) jCaT are events of very low probability.
Spatio-temporal characteristics of jCaT JCaT are larger in spatial spread and last longer than spontaneous Ca 2+ sparks. JCaT always occur with brief latency to the EFS pulse. The spatio-temporal differences between the jCaT and the sparks are obvious in published records [40] : the jCaT is larger in space, lasts longer, and occurs at the time of the stimulus pulse. These characteristics and their pharmacology are how jCaT are distinguished from sparks. The vast majority of jCaT occurred within 12 ms (4 scan lines) after the stimulus pulse. The evidence linking the occurrence of jCaT to the stimulus seems unequivocal. The spatial full-widthat-half-maximum (FWHM) for jCaT is 4.8 µm, and the time taken to fall to half-amplitude, t 1/2 , (from the peak) is 145 ms. The means of these distributions are quite different from those of sparks in smooth muscle (sparks: t 1/2 , 48-56 ms; FWHM, 2.4 µm) [41] . Some jCaT occurred before the stimulus, and some much after; we hypothesize that these are associated with spontaneous neurotransmitter release.
Pharmacology of jCaT Pharmacological studies of jCaT [40] have provided strong evidence that they arise from the activation of purinergic receptors. JCaT persist, apparently unchanged, in the presence of capsaicin, and are thus not dependent on sensory nerves. They are completely absent in the presence of the purinergic receptor blocker, suramin (300 µmol/L). They persist in the presence of α 1 -adrenergic blocker prazosin (10 µmol/L), sufficient to block neurogenic adrenergic responses completely. They are also largely unaffected by ryanodine (30 µmol/L), while Ca 2+ sparks are abolished. Although we favor the hypothesis that jCaT are due to ATP and P2X 1 receptors, further studies are required, particularly to be sure that it is the P2X 1 receptor subtype. NPY is also reported to activate non-specific cation channels [36] and thus it could contribute to jCaT. This possibility could be tested using specific Y 1 receptor antagonists (BIBP 3226).
In our recent study [42] using P2X 1 knockout animals [43] , we clearly showed that jCaT represent Ca 2+ that enter vascu- 
pulses (black arrowheads). A jCaT is seen in the SMC at 4.8 s in the line-scan image. (C) jCaTs often arise at streaks in line-scan images. (D)
A region where a jCaT occurred was scanned repeatedly. In (a) a jCaT occurred. In (b) no jCaT occurred, but a fluorescence transient occurred in the streak. We demonstrate that jCaTs can arise precisely in the region of an electrically excitable nerve fiber (from Lamont & Wier, 2002 [40] ).
lar smooth muscle cells through P2X 1 receptors activated by neurally-released ATP. The P2X 1 knockout models also showed the importance of the involvement of ATP-mediated P2X 1 activation in the initial rapid component of the nerveevoked contraction [42] . Ca 2+ waves: post-synaptic Ca 2+ signals activated by α 1 -adrenergic agonists The Ca 2+ signaling elicited by adrenergic agonists has been studied mainly through the use of exogenous, bath-applied synthetic catecholamines such as the α 1 -adrenoceptor specific agonist, PE. An early study was that of Zang and colleagues [44] , in which it was shown that PE elicited asynchronous propagating Ca 2+ waves in rat mesenteric arteries. The basis of the dose-response to PE was increasing recruitment of individual smooth muscle cells to produce Ca 2+ waves, and to produce them at higher and higher frequencies. As expected, asynchronous propagating Ca 2+ waves seem also to be the response elicited by neurally released NE. This is discussed in more detail later in relation to the activation of contraction by neurally released NE, during neurogenic contractions of small arteries.
Neurogenic contractions of small arteries
The detailed studies on jCaTs described above were performed in pressurized small arteries that did not contract because the electrical stimulation was 'sub-threshold' for contraction. In this section, we review the studies in which jCaT and Ca 2+ waves have been observed during isometric neurogenic contractions. For these studies, the arteries were mounted in a myograph that permitted simultaneous (i) highspeed confocal imaging of fluorescence from individual smooth muscle cells; (ii) electrical stimulation of perivascular nerves; and (iii) recording of isometric tension. Sympathetic neuro-muscular transmission was achieved by EFS (frequency, 10 Hz; pulse voltage, 40 V; pulse duration, 0.2 ms) in the presence of capsaicin and scopolamine (to inhibit 'sensory' and cholinergic nerves, respectively). As shown in Figure 3 , during the first 20 s of EFS, force rose to a small peak, then declined, similar to that recorded previously [45] . During this time, jCaT were present at a relatively high frequency. Propagating asynchronous Ca 2+ waves, previously associated with bath-applied α 1 -adrenoceptor agonists, were not initially present. During the next 2.5 min of EFS, force rose slowly, and asynchronous propagating Ca 2+ waves appeared. The selective α 1 -adrenoceptor antagonist, prazosin, abolished both the slowly developing contraction and the Ca 2+ waves, but reduced the initial transient contraction by only ~25%.
Purinergic component of neurogenic contraction In order to study selectively the arterial contractions generated by neurally-released ATP, arteries were exposed to prazosin (1-10 µmol/L) to block α 1 -adrenergic receptors (Figure 4 ). Others [8] have shown that purinergic receptor antagonists, such as suramin, abolish the small contractions that remain in prazosin. We found that after prazosin treatment 73.7%±14.0% (n=7) of the initial transient contraction remained and 5.00%±0.98% (n=5) of the maintained contraction. We then sought to characterize the changes in frequency and amplitude of jCaT that might occur during the EFS, and which activate contraction. Because the jCaT is a local Ca 2+ signal, it was not necessarily clear that jCaT would activate contraction effectively. Confocal imaging of Fluo-4 fluorescence at 30 images·s -1 was performed for 3 periods of 20 s in the beginning (0-20 s), middle (80-100 s), and end (160-180 s) of 3 min EFS (periods indicated by bars in Figure  4A ). The frequency of jCaT declined markedly during the 3 min of EFS ( Figure 4B , iv-vi). In contrast to the frequency, the peak amplitude of the jCaT changed little during 3 min EFS. JCaT occurred in sufficient numbers during the first 20 s of EFS to produce a detectable elevation of average (Ca 2+ ; fluorescence ratio), which paralleled the transient contraction that occurred during this time. On the other hand, jCaT occurred at a very low frequency later in the EFS, when contractile force fell to very low levels. Thus, it seems reasonable to attribute the contractile activation to jCaT, despite their limited spatial extent and frequency. ; a rate which is too slow to resolve the jCaT [40] generated during the initial purinergic component. For the analysis of the adrenergic component of the experiment illustrated in Figure 5 , 74 individual smooth muscle cells were identified and an AOI placed on each. In these 74 cells, 809 Ca 2+ waves were detected and the time of onset and peak amplitude of each was determined, and the data presented as a histogram. signals is not completely known. Zang et al [44] used confocal laser scanning microscopy and Fluo-4 to visualize Ca 2+ transients within individual smooth muscle cells of rat resistance arteries during α 1 -adrenoceptor activation. They noticed that in the presence of PE, caffeine also elicited a massive release of Ca 2+ , at a time when Ca 2+ waves had died away completely, or when further responses to PE would have been much diminished. This result shows that caffeine-sensitive Ca 2+ stores are not depleted of Ca 2+ in the presence of PE and further indicates that the α 1 -agonist-releasable Ca 2+ store and the caffeine releasable Ca 2+ store are different [44] . More recent experiments by our group (Lamont and Wier, 2004 ) [46] showed that Ins(1,4,5)P 3 R are essential for adrenergically-induced asynchronous Ca 2+ waves and the associated steady vasoconstriction, but RyR are not appreciably opened during adrenergic activation (because PE did not facilitate the development of the effects of ryanodine). Also Ins(1,4,5)P 3 R are not essential for Ca 2+ sparks. This provides an explanation of the fact that adrenergic stimulation decreases the frequency of Ca 2+ sparks (previously reported) while simultaneously increasing the frequency of asynchronous propagating Ca 2+ waves; different SR Ca
Adrenergic component of neurogenic contraction

2+
-release channels are involved [46] . Both the contraction and the underlying Ca 2+ signals during the adrenergic component of the neurogenic isometric contraction are also distinctly different from those occur- [38] ).
ring during externally applied α 1 -adrenoceptor agonist (typically PE). After the initial purinergic component, the adrenergic component of the neurogenic contractions, even at maximally effective EFS, rises much more slowly than does the contraction in response to bath-applied α 1 -adrenoceptor agonist. Maximally effective concentrations of exogenous PE elicit an initial synchronous release of Ca
, followed by asynchronous propagating Ca 2+ waves, both in veins [45] and in the arteries [34, 44] . Thus, the initial rapid rise in force in response to externally applied PE appears to be generated by a synchronous release of Ca 2+ from intracellular stores.
This does not occur during neurogenic contractions, possibly because neuronally released NA does not initially reach the uniformly high levels that are achieved rapidly after external application. [38] ).
Influence of myogenic tone
Another significant complication that arises from arteries pressurized at 70 mmHg above room temperature is the development of tone. Earlier studies (eg Mauban et al [47] ), were at room temperature, which is not conductive for the development of myogenic tone. The only previous study in which spatially resolved imaging was performed in mesenteric small arteries at 37 ºC [48] was complicated by the development of adrenoceptor-mediated vasomotion, preventing clear observation of Ca 2+ signaling in individual smooth muscle. However, mouse mesenteric small arteries at 32 º C showed the development of myogenic tone and also rarely resulted in vasomotion on stimulation by PE. In such arteries, PE elicited only a spatially uniform increase in Ca 2+ with little or no Ca 2+ waves, suggesting that the rise in Ca 2+ i leads to the development of myogenic tone and also inactivation of IP 3 receptors [49] .
Conclusion
The confocal microscope, along with other new technologies has provided much new information on the physiology and pharmacology of sympathetically evoked Ca 2+ signaling in arterial smooth muscle. We have previously advanced a scheme to explain the Ca 2+ signals and isometric contraction elicited by electrical field stimulation of perivascular sympathetic nerves of a rat mesenteric small artery ( Figure 6 ). Early during a train of nerve fiber action potentials, smooth muscle contraction is activated mainly by jCaT induced by neurally released ATP. JCaT are localized to the post-junctional region, and arise from Ca 2+ that has entered via P2X 1 receptors. At this time, sympathetic varicosities may release mainly synaptic vesicles that contain a relatively high concentration of ATP (the relatively few 'big' quanta proposed by Stjarne [12] ). Later during a train of nerve fiber action potentials, jCaT are rare, and contraction is activated by Ca 2+ waves that arise from SR. Ca 2+ release from SR is activated by InsP 3 , produced after the binding of NE to α 1 -adrenoceptors. At this time, sympathetic varicosities may release small synaptic vesicles (the more numerous 'small' quanta, green; Figure 6 ) that contain a relatively high concentration of NE. We stress that the mechanisms accounting for differential release of ATP and NE are quite speculative at this time.
JCaT are distinct from Ca 2+ transients activated in isolated venous myocytes by exogenously applied ATP [50] . Previous studies of the effects of ATP on small arteries utilized spatially averaged measurements of Ca 2+ [51] and we can not determine therefore whether jCaT might be produced by bathapplied ATP or not. In rat mesenteric small arteries similar to those used here, low (0.01-1 mmol/L) concentrations of exogenous ATP caused 'global' Ca 2+ transients that seemed to involve Ca 2+ influx through channels sensitive to nifedipine and the putative blocker of receptor operated channels, SKF 96365 [52] , whereas higher concentrations (1-3 mmol/L) caused a release of Ca 2+ from intracellular stores (Ca 2+ transients were elicited by high ATP in the absence of external Ca ). When applied to isolated venous myocytes, low concentrations of ATP (0.1 µmol/L) induced rather uniform increases in Ca 2+ (which started from the edges of the cell), and at higher concentrations (1 µmol/L), propagating Ca 2+ waves [50] . In the arteries studied here in the presence of prazosin, no propagating Ca 2+ waves were ever observed during EFS. We interpret this to mean that neurally-released ATP does not evoke significant release of Ca 2+ from intracellular stores, a result in agreement with previous pharmacological studies on rat mesenteric small arteries [7] . We speculate that the differences between the effects of bath-applied ATP and neurally-released ATP are due to a markedly different spatio-temporal pattern of ATP on the smooth muscle cell in the 2 cases.
Both the contraction and the underlying Ca 2+ signals during the adrenergic component of the neurogenic isometric contraction are also distinctly different from those occurring during externally applied α 1 -adrenoceptor agonist (typically phenylephrine, PE). After the initial purinergic component, the adrenergic component of the neurogenic contractions, even at maximally effective EFS, rises much more slowly than the contraction in response to bath-applied α 1 -adrenoceptor agonist. Maximally effective concentrations of exogenous PE elicit an initial synchronous release of Ca 2+ , followed by asynchronous propagating Ca 2+ waves, both in veins [53] and arteries [44, 47] . Thus, the initial rapid rise in force in response to externally applied PE appears to be generated by a synchronous release of Ca 2+ from intracellular stores. This does not occur during neurogenic contractions, possibly because neurally-released NE does not initially reach the uniformly high levels that are achieved rapidly after external application.
